Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Total Revenue of $56.94 million for fiscal year 2025.
CHAMPIONS ONCOLOGY, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $56.94M | +13.5% |
| 2024 | $50.16M | -6.9% |
| 2023 | $53.87M | +9.7% |
| 2022 | $49.11M | +19.7% |
| 2021 | $41.04M | +27.8% |
| 2020 | $32.12M | +18.7% |
| 2019 | $27.07M | +33.7% |
| 2018 | $20.24M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $16.56M | -2.8% | +10.1% |
| October 31, 2025 | $15.04M | +11.5% | +7.4% |
| July 31, 2025 | $13.99M | -0.5% | -17.9% |
| January 31, 2025 | $17.04M | +41.8% | +26.3% |
| October 31, 2024 | $13.49M | +16.6% | -4.1% |
| July 31, 2024 | $14.06M | +11.9% | +17.0% |
| January 31, 2024 | $12.02M | -5.9% | +3.9% |
| October 31, 2023 | $11.57M | -19.0% | -7.9% |
- CHAMPIONS ONCOLOGY, INC. showed an increase of +13.5% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, CHAMPIONS ONCOLOGY, INC.’s total revenue has grown by 181.3% (from $20.24 million to $56.94 million).
- The most recent figure is from CHAMPIONS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: